{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:18:11Z","timestamp":1757629091697,"version":"3.44.0"},"reference-count":25,"publisher":"Harborside Press, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Geriatric assessment (GA) can be used to identify patient-specific deficits and facilitate interventions to improve patient outcomes. In this randomized pilot clinical trial, we hypothesized that geriatric assessment with or without geriatrician comanagement can reduce the risk of hospitalization for older adults with head and neck cancer receiving concurrent chemoradiotherapy (CRT). <jats:bold>Patients and Methods:<\/jats:bold> Patients aged \u226565 years with newly diagnosed or postoperative mucosal head and neck squamous cell carcinomas were eligible for enrollment and received 6 to 7 weeks of CRT. All patients completed an electronic GA and were randomized to either a geriatric consultation for comanagement of geriatric-specific deficits or management of geriatric deficits by the radiation oncology team without geriatric consultation. All patients were seen twice weekly in the radiation oncology clinic to enhance supportive care. The primary endpoint was the rate of hospitalization during CRT. <jats:bold>Results:<\/jats:bold> A total of 30 patients were randomized, with 14 ultimately eligible to proceed in each study arm. Median age was 75 years (range, 65\u201381) and the median number of geriatric deficits was 4 (range, 1\u201310). The most common geriatric deficits were symptoms of depression, social activity limitation, and lack of social support. The overall hospitalization rate was 42.9% (12\/28; 95% CI, 24.5%\u201362.8%), with 64.3% (9\/14; 95% CI, 35.1%\u201387.2%) and 21.4% (3\/14; 95% CI, 4.7%\u201350.8%) of patients hospitalized in the geriatric comanagement and GA-guided supportive care arms, respectively. Accumulated geriatric deficits (AGDs) and history of falls were both strongly predictive of the risk of hospitalization (<jats:italic>P<\/jats:italic>=.0061 and <jats:italic>P<\/jats:italic>=.044, respectively). No deaths occurred during treatment or within 30 days of completing CRT. <jats:bold>Conclusions:<\/jats:bold> AGDs and history of falls were strong predictors of hospitalization risk. Both geriatric comanagement and GA-guided supportive care were implemented with high compliance, but GA-guided supportive care involves a lower resource burden for widespread implementation.<\/jats:p>","DOI":"10.6004\/jnccn.2025.7042","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T17:58:52Z","timestamp":1755194332000},"source":"Crossref","is-referenced-by-count":0,"title":["Randomized Clinical Trial of Geriatric Comanagement Versus Geriatric Assessment\u2013Guided Supportive Care for Older Patients With Head and Neck Cancer"],"prefix":"10.6004","volume":"23","author":[{"given":"Kaveh","family":"Zakeri","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir H.","family":"Safavi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphna","family":"Gelblum","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Shahrokni","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Kopke","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnia","family":"Amirnia","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Wu","family":"Sun","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshy","family":"Alexander","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Korc-Grodzicki","sequence":"additional","affiliation":[{"name":"Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Radiother Oncol","first-page":"4","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon JP","year":"2009","unstructured":"Pignon JP, le Ma\u00eetre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4\u201314."},{"key":"B2","series-title":"J Clin Oncol","first-page":"3582","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis","volume":"26","author":"Machtay M","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A,  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582\u20133589."},{"key":"B3","series-title":"Cancer","first-page":"1345","article-title":"The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era","volume":"123","author":"Zumsteg ZS","year":"2017","unstructured":"Zumsteg ZS, Lok BH, Ho AS,  The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era. Cancer 2017;123:1345\u20131353."},{"key":"B4","series-title":"Lancet Oncol","first-page":"e274","article-title":"Management of older patients with locoregionally confined head and neck cancer","volume":"18","author":"Porceddu SV","year":"2017","unstructured":"Porceddu SV, Haddad RI. Management of older patients with locoregionally confined head and neck cancer. Lancet Oncol 2017;18:e274\u2013283."},{"key":"B5","series-title":"Int J Radiat Oncol Biol Phys","first-page":"850","article-title":"Geriatric assessment as a predictor of tolerance, quality of life, and outcomes in older patients with head and neck cancers and lung cancers receiving radiation therapy","volume":"98","author":"VanderWalde NA","year":"2017","unstructured":"VanderWalde NA, Deal AM, Comitz E,  Geriatric assessment as a predictor of tolerance, quality of life, and outcomes in older patients with head and neck cancers and lung cancers receiving radiation therapy. Int J Radiat Oncol Biol Phys 2017;98:850\u2013857."},{"key":"B6","series-title":"J Clin Oncol","first-page":"2595","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers H","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M,  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32:2595\u20132603."},{"key":"B7","series-title":"J Clin Oncol","first-page":"2647","article-title":"Surgical considerations in older adults with cancer","volume":"32","author":"Korc-Grodzicki B","year":"2014","unstructured":"Korc-Grodzicki B, Downey RJ, Shahrokni A,  Surgical considerations in older adults with cancer. J Clin Oncol 2014;32:2647\u20132653."},{"key":"B8","series-title":"J Oncol Pract","first-page":"95","article-title":"How we care for an older patient with cancer","volume":"13","author":"Shahrokni A","year":"2017","unstructured":"Shahrokni A, Kim SJ, Bosl GJ, Korc-Grodzicki B. How we care for an older patient with cancer. J Oncol Pract 2017;13:95\u2013102."},{"key":"B9","series-title":"JAMA Netw Open","first-page":"e209265.","article-title":"Association of geriatric comanagement and 90-day postoperative mortality among patients aged 75 years and older with cancer","volume":"3","author":"Shahrokni A","year":"2020","unstructured":"Shahrokni A, Tin AL, Sarraf S,  Association of geriatric comanagement and 90-day postoperative mortality among patients aged 75 years and older with cancer. JAMA Netw Open 2020;3:e209265."},{"key":"B10","series-title":"Gynecol Oncol","first-page":"77","article-title":"Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center","volume":"154","author":"Filippova OT","year":"2019","unstructured":"Filippova OT, Chi DS, Long Roche K,  Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center. Gynecol Oncol 2019;154:77\u201382."},{"key":"B11","series-title":"J Natl Compr Canc Netw","first-page":"172","article-title":"Electronic rapid fitness assessment: a novel tool for preoperative evaluation of the geriatric oncology patient","volume":"15","author":"Shahrokni A","year":"2017","unstructured":"Shahrokni A, Tin A, Downey RJ,  Electronic rapid fitness assessment: a novel tool for preoperative evaluation of the geriatric oncology patient. J Natl Compr Canc Netw 2017;15:172\u2013179."},{"key":"B12","series-title":"J Geriatr Oncol","first-page":"228","article-title":"Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment","author":"Raab G","year":"2022","unstructured":"Raab G, Restifo D, McBride SM,  Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment. J Geriatr Oncol 2022;13:228\u2013233."},{"key":"B13","series-title":"Adv Radiat Oncol","first-page":"101096.","article-title":"Correlation of an electronic geriatric assessment with receipt of adjuvant radiation and chemotherapy in older adults with head and neck cancer","volume":"8","author":"Restifo D","year":"2023","unstructured":"Restifo D, Raab G, McBride SM,  Correlation of an electronic geriatric assessment with receipt of adjuvant radiation and chemotherapy in older adults with head and neck cancer. Adv Radiat Oncol 2023;8:101096."},{"key":"B14","series-title":"J Clin Oncol","first-page":"3652","article-title":"System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): a prospective randomized study of machine learning-directed clinical evaluations during radiation and chemoradiation","volume":"38","author":"Hong JC","year":"2020","unstructured":"Hong JC, Eclov NCW, Dalal NH,  System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): a prospective randomized study of machine learning-directed clinical evaluations during radiation and chemoradiation. J Clin Oncol 2020;38:3652\u20133661."},{"key":"B15","series-title":"Head Neck","first-page":"2207","article-title":"Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer","volume":"45","author":"Han J","year":"2023","unstructured":"Han J, Zakeri K, Raab G,  Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. Head Neck 2023;45:2207\u20132216."},{"key":"B16","series-title":"J Clin Oncol","first-page":"3858","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan PF","year":"2014","unstructured":"Nguyen-Tan PF, Zhang Q, Ang KK,  Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol 2014;32:3858\u20133866."},{"key":"B17","series-title":"J Clin Oncol","first-page":"2940","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang KK","year":"2014","unstructured":"Ang KK, Zhang Q, Rosenthal DI,  Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol 2014;32:2940\u20132950."},{"key":"B18","series-title":"Lancet","first-page":"40","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison ML","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J,  Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 2019;393:40\u201350."},{"key":"B19","series-title":"Int J Radiat Oncol Biol Phys","first-page":"46","article-title":"Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study","volume":"79","author":"Huang SH","year":"2011","unstructured":"Huang SH, O\u2019Sullivan B, Waldron J,  Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys 2011;79:46\u201351."},{"key":"B20","series-title":"Clin Oncol (R Coll Radiol)","first-page":"835","article-title":"Ninety day mortality after radical radiotherapy for head and neck cancer","volume":"29","author":"Dixon L","year":"2017","unstructured":"Dixon L, Garcez K, Lee LW,  Ninety day mortality after radical radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol) 2017;29:835\u2013840."},{"key":"B21","series-title":"Lancet","first-page":"1894","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile SG","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H,  Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet 2021;398:1894\u20131904."},{"key":"B22","series-title":"JAMA Oncol","first-page":"e214158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li D","year":"2021","unstructured":"Li D, Sun CL, Kim H,  Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol 2021;7:e214158."},{"key":"B23","series-title":"Br J Cancer","first-page":"1949","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund CM","year":"2021","unstructured":"Lund CM, Vistisen KK, Olsen AP,  The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer 2021;124:1949\u20131958."},{"key":"B24","series-title":"Cancers (Basel)","first-page":"3290","article-title":"Effectiveness of geriatric assessment-driven interventions on survival and functional and nutritional status in older patients with head and neck cancer: a randomized controlled trial (EGeSOR)","volume":"14","author":"Paillaud E","year":"2022","unstructured":"Paillaud E, Brugel L, Bertolus C,  Effectiveness of geriatric assessment-driven interventions on survival and functional and nutritional status in older patients with head and neck cancer: a randomized controlled trial (EGeSOR). Cancers (Basel) 2022;14:3290."},{"key":"B25","series-title":"J Natl Cancer Inst","first-page":"758","article-title":"Geriatric assessment and quality of life for 2 years in older patients with head and neck cancer","volume":"116","author":"Lafont C","year":"2024","unstructured":"Lafont C, Paillaud E, Bertolus C,  Geriatric assessment and quality of life for 2 years in older patients with head and neck cancer. J Natl Cancer Inst 2024;116:758\u2013763."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/9\/article-e257042.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/9\/article-e257042.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/9\/article-e257042.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:25:40Z","timestamp":1757507140000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/9\/article-e257042.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.7042","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}